Prefrontal cortex circuits in depression and anxiety: contribution of discrete neuronal populations and target regions

Our understanding of depression and its treatment has advanced with the advent of ketamine as a rapid-acting antidepressant and the development and refinement of tools capable of selectively altering the activity of populations of neuronal subtypes. This work has resulted in a paradigm shift away fr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular psychiatry 2020-11, Vol.25 (11), p.2742-2758
Hauptverfasser:	Hare, Brendan D., Duman, Ronald S.
Format:	Artikel
Sprache:	eng
Schlagworte:	631/378 692/699/476/1414 Antidepressants Antidepressive Agents - pharmacology Antidepressive Agents - therapeutic use Anxiety Anxiety - drug therapy Anxiety - pathology Behavioral Sciences Biological Psychology Brain Depression - drug therapy Depression - pathology Depression, Mental Ketamine Ketamine - pharmacology Ketamine - therapeutic use Magnetic fields Medicine Medicine & Public Health Mental depression Neural Pathways - drug effects Neurons Neurosciences Pharmacotherapy Prefrontal cortex Prefrontal Cortex - drug effects Prefrontal Cortex - pathology Psychiatry Review Article Transcranial magnetic stimulation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!